Pipeline Biology internship 2021-22
- Do you have a strong motivation to learn about drug development, especially in the cell biology field?
- Are you strongly motivated to work in a laboratory environment – or have recent experience of working in a lab?)
- Do you love working as part of a team?
If the answer is YES! to all of the above, please read on…
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease. We are developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs.
Our most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies. The company also recently completed its Initial Public Offering and was listed on the NASDAQ.
We pride ourselves on our long-standing and established academic collaborations and as a result, we have an opportunity for a 12-month Internship programme in our Pipeline Biology Group. We are looking for an enthusiastic and highly motivated individual who would relish the chance to learn from Immunocores cutting edge science and corporate growth.
CLOSING DATE - 29th April 2021
INTERVIEWS - w/c 17th and 24th May 2021
If this opportunity excites you, please don’t hesitate in applying today!